help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheibani, K.
Right arrow Articles by Rappaport, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheibani, K.
Right arrow Articles by Rappaport, H.

American Journal of Pathology, Vol 124, 310-318, Copyright © 1986 by American Society for Investigative Pathology


REGULAR ARTICLES

Monocytoid B-cell lymphoma. A novel B-cell neoplasm

K Sheibani, CC Sohn, JS Burke, CD Winberg, AM Wu and H Rappaport

Monocytoid B lymphocytes (MBLs), originally described as part of the histologic picture of toxoplasmic lymphadenitis, have been recognized as a reactive component in a variety of lymph node disorders. The authors now report 3 cases of non-Hodgkin's lymphoma in which a multidisciplinary approach allowed them to confirm the existence of a malignant lymphoma composed of the neoplastic counterpart of the MBLs found in nonneoplastic disorders. In all 3 cases, the lymphoma was composed of a relatively monomorphous infiltrate of atypical MBLs that had rather uniform-appearing nuclei and had well-defined, moderately abundant pale cytoplasm. The pattern of lymph node involvement in all 3 cases was predominantly sinusoidal and interfollicular. The neoplastic lymphoid cells were strongly positive for B-cell-restricted antigens; the light- and heavy-chain phenotypes were kappa-IgM (2 cases) and kappa-IgG (1 case). In all 3 cases, rearrangement of heavy- and/or light-chain genes was clearly identified by Southern blot hybridization. The name "monocytoid B-cell lymphoma" is proposed for this newly described malignant B-cell neoplasm.


This article has been cited by other articles:


Home page
BloodHome page
F. Berger, P. Felman, C. Thieblemont, T. Pradier, L. Baseggio, P.-A. Bryon, G. Salles, E. Callet-Bauchu, and B. Coiffier
Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients
Blood, March 15, 2000; 95(6): 1950 - 1956.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
B. N. Nathwani, J. R. Anderson, J. O. Armitage, F. Cavalli, J. Diebold, M. R. Drachenberg, N. L. Harris, K. A. MacLennan, H. K. Muller-Hermelink, F. A. Ullrich, et al.
Marginal Zone B-Cell Lymphoma: A Clinical Comparison of Nodal and Mucosa-Associated Lymphoid Tissue Types
J. Clin. Oncol., August 1, 1999; 17(8): 2486 - 2486.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Tierens, J. Delabie, S. Pittaluga, A. Driessen, and C. DeWolf-Peeters
Mutation Analysis of the Rearranged Immunoglobulin Heavy Chain Genes of Marginal Zone Cell Lymphomas Indicates an Origin From Different Marginal Zone B Lymphocyte Subsets
Blood, April 1, 1998; 91(7): 2381 - 2386.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. D. Jennings and K. A. Foon
Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy
Blood, October 15, 1997; 90(8): 2863 - 2892.
[Full Text] [PDF]


Home page
BloodHome page
The Non-Hodgkin's Lymphoma Classification Project
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma
Blood, June 1, 1997; 89(11): 3909 - 3918.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. O. Armitage
Treatment of Non-Hodgkin's Lymphoma
N. Engl. J. Med., April 8, 1993; 328(14): 1023 - 1030.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the American Society for Investigative Pathology.